This section hosts guidelines, manuals and toolkits to strengthen public health practice.
The WHO Therapeutics and COVID-19: Living Guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in COVID-19 treatment. This sixth version of the WHO guideline contains nine recommendations, including two new recommendations regarding the use of a combination of neutralizing monoclonal antibodies, casirivimab and imdevimab. No further updates to the previous existing recommendations were made in this latest version. Links to the earlier versions of this guidance are also available on this page. It is a useful document for medical practitioners. Click here to read the guidelines.